This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08552/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08552/identifier/drugbank/
n14http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB08552/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08552/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://linked.opendata.cz/resource/drugbank/drug/DB08552/identifier/pubchem-compound/

Statements

Subject Item
n2:DB08552
rdf:type
n3:Drug
n3:description
(1R)-1-(2-thienylacetylamino)-1-phenylmethylboronic acid is a solid. This compound belongs to the benzenes and substituted derivatives. These are aromatic compounds containing at least one benzene ring. This medication targets the protein beta-lactamase.
n3:group
experimental
owl:sameAs
n11:DB08552 n14:DB08552
dcterms:title
(1R)-1-(2-thienylacetylamino)-1-phenylmethylboronic acid
adms:identifier
n6:5289378 n7:99445023 n8:DB08552 n9:SM3 n12:4451364
n3:IUPAC-Name
n4:271B6338-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B633E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B633D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B633A-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B633B-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B633C-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B6336-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B6334-363D-11E5-9242-09173F13E4C5 n4:271B6337-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B6335-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B6344-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B6345-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B633F-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B6340-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B6342-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B6341-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B6343-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B634A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B634C-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B634D-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B6349-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B6348-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B634B-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B6339-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B6346-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B6347-363D-11E5-9242-09173F13E4C5